Oncology

Metastatic Breast Cancer

Expert Perspectives® in HR+/HER2- Metastatic Breast Cancer to Cover Key Topics in HR+/HER2- Metastatic Breast Cancer Treatment

expert perspectives by Joanne Mortimer, MD, FACP, FASCO; David Rimm, MD, PhD

Overview

Expert Perspectives^® delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. Expert Perspectives^® in HR+/HER2- Metastatic Breast Cancer will feature community-selected experts and topics that we hope you will find of value in your clinical practice.

VIEW THE TOPICS:

Patient Care Perspectives

Preventing and Managing Osteoporosis in Patients With Metastatic Breast Cancer
Special Considerations in Treating Older Adults With Metastatic Breast Cancer

Clinical Topic Updates

Recent Data With CDK4/6 Inhibitors for Metastatic HR+ HER2- Breast Cancer
Treating Patients With ESR1-Mutated Metastatic HR+ HER2- Breast Cancer

Expert Roundtables

Expert Roundtable Podcast: Treating Patients With HR+ HER2- Metastatic Breast Cancer Eligible for Multiple Targeted Therapies
Later-Line Treatment for Metastatic HR+ HER2– Breast Cancer

Profile

Joanne Mortimer, MD, FACP, FASCO

Baum Family Professor in Women’s Cancers
Associate Director for Cancer Research Training and Education Coordination
Vice Chair and Professor
Department of Medical Oncology and Therapeutics Research
Comprehensive Cancer Center
City of Hope
Duarte, CA

Profile

David Rimm, MD, PhD

Anthony N. Brady Professor of Pathology
Departments of Pathology and Medicine (Medical Oncology)
Director, Yale Pathology Tissue Services
Director, Lab for Quantitative Diagnostics in Anatomic Pathology
Yale School of Medicine
New Haven, CT